Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

40,350 stories, page 398 of 673

Advanced search

🌍Jul 28discoverynews.google.comTier 3 · Aggregated media

SARTORIUS STEDIM BIOTECH : Buy rating from Bernstein

marketscreener.comOriginal source

🌍Jul 28discoverynews.google.comTier 3 · Aggregated media

Edison issues report on BB Biotech (BION)

TradingViewOriginal source

🌍Jul 28discoverynews.google.comTier 2 · Trade media

An eye drug biotech banks $118M and stocks its executive suite

BioPharma DiveOriginal source

🌍Jul 28discoverynews.google.comTier 3 · Aggregated media

Stay Ahead of the Game With Teva Pharmaceutical Industries (TEVA) Q2 Earnings: Wall Street's Insights on Key Metrics

Yahoo FinanceOriginal source

🌍Jul 28discoverynews.google.comTier 3 · Aggregated media

Amgen makes case to continue selling drug that FDA links to deaths

The Business JournalsOriginal source

🌍Jul 28discoverynews.google.comTier 3 · Aggregated media

FDA approves first over-the-counter Tylenol & Naproxen tab for 12-hour pain relief

Indian Pharma PostOriginal source

🌍Jul 28discoverynews.google.comTier 3 · Aggregated media

Recce Pharmaceuticals (ASX:RCE) Advances Phase 3 Trials and MENA Licensing Strategy as Commercial Pathway Develops

KalkineOriginal source

🌍Jul 28discoverynews.google.comTier 3 · Aggregated media

Legend Biotech names interim CEO after Ying Huang steps down

The Pharma LetterOriginal source

🇺🇸Jul 28Devicesviz.aiTier 1 · Company source

A Decade of Increasing Access to Life Saving Treatments: Viz.ai Celebrates 10 Years, 2,000 Hospitals, and 230 Million Patients

Viz.aiOriginal source

🇺🇸Jul 28CDMOagcbio.comTier 2 · Direct publisher

AGC Biologics Lands Commercial Manufacturing Agreement for Yokohama Site Worth Hundreds of Millions of Dollars

AGC BiologicsOriginal source

🌍Jul 28discoverynews.google.comTier 3 · Aggregated media

Pharmaceutical Ad Urges Viewers To Fight Doctors Who Say Drug Not Right For Them

The OnionOriginal source

🌍Jul 28discoverynews.google.comTier 3 · Aggregated media

AI in Pharmaceutical Manufacturing: Executive Handbook on AI Readiness, Digital Maturity and Factory Transformation

EIN PresswireOriginal source

🇺🇸Jul 28Industryir.codexis.comTier 1 · Company source

Codexis to Report Second Quarter 2026 Financial Results on August 11

CodexisOriginal source

🌍Jul 28discoverynews.google.comTier 3 · Aggregated media

FDA Suspends FSSAI Licence Of Fort's Poornima Restaurant Over Fungal Food and Hygiene Violations

lokmattimes.comOriginal source

🌍Jul 28discoverynews.google.comTier 2 · Trade media

Boston Scientific unveils major restructuring, plots job cuts amid savings drive

Fierce BiotechOriginal source

🇺🇰Jul 28Regulatorygov.ukTier 1 · Regulatory source

Botulism: clinical and public health management

Information for healthcare professionals on the diagnosis and treatment of infant botulism, foodborn...

UK Health Security AgencyOriginal source

🌍Jul 28discoverynews.google.comTier 3 · Aggregated media

Vanguard Health Care ETF Outperforms VanEck Biotech on Returns, Yield, and Fees

The Motley FoolOriginal source

🇩🇪Jul 28Researchuni-heidelberg.deTier 2 · Direct publisher

4EU+ European University Alliance Goes into Third Funding Period

Heidelberg UniversityOriginal source

🌍Jul 28Medianovartis.comTier 3 · Secondary coverage

Smarter decisions at scale: How Novartis is using AI to advance R&D

NovartisOriginal source

🇺🇰Jul 28Regulatorygov.ukTier 1 · Regulatory source

Bioscience and health technology sector statistics 2024 to 2025

Official statistics in development estimating the size and composition of the life sciences sector i...

UK Department of Health and Social CareOriginal source

🌍Jul 28discoverynews.google.comTier 3 · Aggregated media

EU governments set to address biotech and economic security

Research Professional NewsOriginal source

🌍Jul 28Industryrelmada.comTier 1 · Company source

Relmada Therapeutics Appoints Uro-Oncology Leader Bipin Dalmia as Chief Business Officer

Relmada TherapeuticsOriginal source

🌍Jul 28discoverynews.google.comTier 3 · Aggregated media

Oak Hill Bio Announces Dosing of First Participant in BEACON Phase 3 Clinical Trial of Rugonersen in Angelman Syndrome

The Manila TimesOriginal source

🌍Jul 28discoverynews.google.comTier 3 · Aggregated media

Dasher Neuroscience Completes Patient Enrollment in Phase 2 Global Clinical Trial of Lead AI Drug Candidate YA-101 for Multiple System Atrophy (MSA)

PR NewswireOriginal source

🌍Jul 28discoverynews.google.comTier 3 · Aggregated media

Chip Parkinson on Direct-to-Patient's Big Year

Pharmaceutical CommerceOriginal source

🇺🇰Jul 28Industrygsk.comTier 1 · Company source

GSK to establish new flagship R&D centre on Cambridge Biomedical Campus, UK

GSK NewsOriginal source

🇺🇸Jul 28Devicesapyxmedical.comTier 1 · Company source

Apyx Medical Corporation to Participate in the Canaccord Genuity 46th Annual Growth Conference

Apyx MedicalOriginal source

🌍Jul 28discoverynews.google.comTier 3 · Aggregated media

Five-Gate Framework Proposed for India-UK Pharmaceutical Trade Agreement Implementation

geneonline.comOriginal source

🇺🇰Jul 28Industrygsk.comTier 1 · Company source

GSK delivers strong Q2 core results performance and continued momentum. Plans announced to accelerate R&D and late-stage pipeline portfolio. Expect 20+ phase III trial starts in 2026

GSK NewsOriginal source

🇨🇦Jul 28Regulatoryrecalls-rappels.canada.caTier 1 · Regulatory source

Oxygen 100%: Gas cylinders containing commercial grade oxygen

Gas cylinders containing industrial grade oxygen were delivered instead of medical grade oxygen.

Health Canada Recalls and Safety AlertsOriginal source

🇨🇦Jul 28Regulatoryrecalls-rappels.canada.caTier 1 · Regulatory source

IQecg® Digital ECG

Affected IQecg® plugin software may produce incorrect ECG waveforms and inaccurate heart-rate calcul...

Health Canada Recalls and Safety AlertsOriginal source

🌍Jul 28discoverynews.google.comTier 3 · Aggregated media

A webcast will carry Legend Biotech's Q2 results review Aug. 11

Stock TitanOriginal source

🌍Jul 28discoverynews.google.comTier 3 · Aggregated media

Legend Biotech to Host Investor Conference Call on Second Quarter 2026 Results

Yahoo FinanceOriginal source

🌍Jul 28discoverynews.google.comTier 3 · Aggregated media

Oak Hill Bio Announces Dosing of First Participant in

GlobeNewswireOriginal source

🌍Jul 28discoverynews.google.comTier 3 · Aggregated media

Trevi Therapeutics to present at August biotech conferences on its chronic cough therapy Haduvio™

PluangOriginal source

🌍Jul 28Mediaheartsciences.comTier 2 · Direct publisher

Fortitude Energizes 12 MW Grand Island, Nebraska Facility, Expanding Owned-and-Operated Power Portfolio

HeartSciencesOriginal source

🌍Jul 28discoverynews.google.comTier 3 · Aggregated media

Jordanian Pharmaceutical Manufacturing Q2 Profit 1.9 Million Dinars

TradingViewOriginal source

🌍Jul 28discoverynews.google.comTier 3 · Aggregated media

Nasus Pharma Appoints Pharmaceutical Industry Veteran Brendan P. O'grady As Chief Executive Officer To Lead Strategic Growth

TradingViewOriginal source

🌍Jul 28discoverynews.google.comTier 3 · Aggregated media

Nasus Pharma Appoints Pharmaceutical Industry Veteran Brendan P. O'Grady as Chief Executive Officer to Lead Strategic Growth

The Manila TimesOriginal source

🌍Jul 28discoverynews.google.comTier 3 · Aggregated media

GSK beats consensus forecast in second quarter

medwatch.comOriginal source

🌍Jul 28discoverynews.google.comTier 3 · Aggregated media

H.C. Wainwright reiterates Buy on Legend Biotech stock, $65 target

Investing.comOriginal source

🌍Jul 28discoverynews.google.comTier 3 · Aggregated media

Nasus Pharma Appoints Pharmaceutical Industry Veteran Brendan P. O'Grady as Chief Executive Officer to Lead Strategic Growth

marketscreener.comOriginal source

🌍Jul 28discoverynews.google.comTier 3 · Aggregated media

Teva Pharmaceutical Industries Ltd. $TEVA is Rubric Capital Management LP's 4th Largest Position

MarketBeatOriginal source

🇺🇰Jul 28Researchmedsci.ox.ac.ukTier 2 · Direct publisher

Tommy’s National Centre for Miscarriage Research celebrates ten years of progress

Oxford MedicineOriginal source

🌍Jul 28discoverynews.google.comTier 3 · Aggregated media

Grace Therapeutics Says FDA Minutes Confirm No Clinical Safety or Efficacy Deficiencies in GTx-104 Review, Advances Dual-Source Manufacturing Plan Toward NDA Resubmission

Quiver QuantitativeOriginal source

🌍Jul 28discoverynews.google.comTier 3 · Aggregated media

Atea Pharmaceuticals Reports Positive Phase 3 C-BEYOND Results for Bemnifosbuvir/Ruzasvir in Hepatitis C, Achieving Non-Inferiority to Epclusa

Quiver QuantitativeOriginal source

🇺🇰Jul 28Researchmedsci.ox.ac.ukTier 2 · Direct publisher

Trial exploring effects of drug on liver in psoriasis patients recruits first UK patient

Oxford MedicineOriginal source

🇺🇰Jul 28Industrygsk.comTier 1 · Company source

GSK’s licensor Hansoh Pharma announces positive results from a second phase III trial for Ris-Rez in China

GSK NewsOriginal source

🌍Jul 28discoverynews.google.comTier 3 · Aggregated media

Atea's 8-week hepatitis C regimen posts 93.5% cure rate

Stock TitanOriginal source

🌍Jul 28discoverynews.google.comTier 3 · Aggregated media

Grace Therapeutics Advances Second U.S. Manufacturing Route for GTx-104

Stock TitanOriginal source

🇺🇸Jul 28Devicesir.idexx.comTier 1 · Company source

IDEXX Releases 2025 Corporate Responsibility Report, Highlighting Progress Against Its Goals

IDEXX LaboratoriesOriginal source

🌍Jul 28discoverynews.google.comTier 3 · Aggregated media

Insiders In Kane Biotech Still Down 40% On CA$1.70m Investment

simplywall.stOriginal source

🌍Jul 28discoverynews.google.comTier 3 · Aggregated media

Sihuan Pharmaceutical Holdings Group (SEHK:460) Looks Pricey On 2026 Earnings Guidance

simplywall.stOriginal source

🌍Jul 28discoverynews.google.comTier 3 · Aggregated media

China's biotech rise to face challenges from US policy responses

The Pharma LetterOriginal source

🌍Jul 28discoverynews.google.comTier 3 · Aggregated media

Singapore: HST Medical acquired by Kowa Pharmaceutical Asia to scale health brands globally

Investors in HealthcareOriginal source

🌍Jul 28discoverynews.google.comTier 2 · Trade media

Preliminary trial results suggest a path to a safer Alzheimer’s treatment

STATOriginal source

🌍Jul 28discoverynews.google.comTier 3 · Aggregated media

Integrated care pathway in individuals with Long COVID: STIMULATE-ICP, a cluster-randomized, phase 3 trial

NatureOriginal source

🇩🇪Jul 28Researchuni-heidelberg.deTier 2 · Direct publisher

The University Celebrates with Visitors from all Over the World

Heidelberg UniversityOriginal source

🌍Jul 28discoverynews.google.comTier 3 · Aggregated media

SBI Securities Starts Takeda Pharmaceutical at Neutral with 5,400 Yen Price Target

marketscreener.comOriginal source

🌍Jul 28discoverynews.google.comTier 3 · Aggregated media

Parkinson’s Disease Drug Trial Extended Following Early Findings

Technology NetworksOriginal source